Limited association between <scp>HRR</scp> gene alterations and <scp>HRD</scp> in molecular tumor board cancer samples: Who should be tested for <scp>HRD</scp>?Christoph Schubart, Evgeny A. Moskalev, Annett Hölsken et al.|International Journal of Cancer|2025Cited by 1
Su1895 Plasma Methylated Sept9 is a Screening Marker in Both Left- and Right-Sided Colon Cancer. Comparison to FOBT and CEA ResultsKinga Tóth, Béla Molnár, Jürgen K. Beck et al.|Gastroenterology|2012Cited by 0
Comparison of plasma methylated SEPT9 screening marker in both left- and right-sided colon cancer to GFOBT and CEA resultsKatalin Tóth, Zsolt Tulassay, Alexandra Kalmár et al.|Zeitschrift für Gastroenterologie|2012Cited by 0